A novel central nervous system embryonal tumor successfully treated with multi-modal therapy highlights limitation of methylation-based tumor classification

Pediatr Blood Cancer. 2022 May;69(5):e29520. doi: 10.1002/pbc.29520. Epub 2021 Dec 16.

Ritu Lamichhane¹, Paromita Roy², Cynthia Hawkins^{3

4}, Lateef Zameer², Anisha Gehani⁵, Rimpa B Achari⁶, Ben Ho⁴, Annie Huang^{4

7}, Uri Tabori^{4

7}, Vijay Ramaswamy^{4

7}, Reghu K Sukumaran¹, Anirban Das^{1

4

7}

¹ Department of Paediatric Haematology Oncology, Tata Medical Center, Kolkata, India.
² Department of Pathology, Tata Medical Center, Kolkata, India.
³ Department of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, Canada.
⁴ The Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Canada.
⁵ Department of Radiology, Tata Medical Center, Kolkata, India.
⁶ Department of Radiation Oncology, Tata Medical Center, Kolkata, India.
⁷ Division of Haematology Oncology, Department of Paediatrics, Hospital for Sick Children, Toronto, Canada.

No abstract available

Publication types